A detailed history of Sargent Bickham Lagudis LLC transactions in Schrodinger, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 250 shares of SDGR stock, worth $5,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 200 25.0%
Holding current value
$5,340
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$16.24 - $26.38 $811 - $1,319
50 Added 25.0%
250 $0
Q3 2021

Nov 05, 2021

BUY
$53.75 - $76.55 $5,375 - $7,655
100 Added 100.0%
200 $11,000
Q4 2020

May 24, 2021

BUY
$48.06 - $84.4 $4,806 - $8,440
100 New
100 $8,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.32B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.